Teleflex Incorporated (NYSE:TFX) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC lowered its stake in Teleflex Incorporated (NYSE:TFX) by 28.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 17,342 shares of the medical technology company’s stock after selling 6,959 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Teleflex were worth $3,105,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the stock. Thompson Investment Management Inc. grew its stake in shares of Teleflex by 31.5% in the fourth quarter. Thompson Investment Management Inc. now owns 3,340 shares of the medical technology company’s stock valued at $594,000 after buying an additional 800 shares in the last quarter. Entropy Technologies LP grew its stake in Teleflex by 20.9% during the 4th quarter. Entropy Technologies LP now owns 6,789 shares of the medical technology company’s stock valued at $1,208,000 after purchasing an additional 1,173 shares in the last quarter. Empowered Funds LLC acquired a new stake in Teleflex during the 4th quarter valued at approximately $259,000. Apollon Wealth Management LLC grew its stake in Teleflex by 10.8% during the 4th quarter. Apollon Wealth Management LLC now owns 1,689 shares of the medical technology company’s stock valued at $301,000 after purchasing an additional 165 shares in the last quarter. Finally, Lecap Asset Management Ltd. acquired a new stake in Teleflex during the 4th quarter valued at approximately $729,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analyst Ratings Changes

TFX has been the subject of a number of recent analyst reports. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Truist Financial lowered their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Mizuho lowered their price objective on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Finally, Royal Bank of Canada decreased their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $252.50.

Teleflex Price Performance

Shares of TFX opened at $175.13 on Friday. The firm has a market cap of $8.13 billion, a price-to-earnings ratio of 34.82, a PEG ratio of 1.67 and a beta of 1.16. Teleflex Incorporated has a 52 week low of $165.62 and a 52 week high of $252.56. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The stock has a 50 day moving average of $177.23 and a 200-day moving average of $208.03.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.